| Filed On | Filing |
|---|---|
| 13 Nov 2026 | SCHEDULE 13G/A |
| 09 Nov 2026 |
8-K: Results of Operations and Financial Condition
SAN DIEGO, November 9, 2026 — ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the quarter ended September 30, 2026, and provided a company update. |
| 09 Nov 2026 | 10-Q |
| 17 Aug 2026 |
Form 4: Yarema Kristin, Director
Received 254,800 shares as a grant or award · Granted 137,200 Employee Stock Option (right to buy) · Granted 250,000 Employee Stock Option (Right to Buy) |
| 17 Aug 2026 |
Form 4: Grant-Huerta Yanina, Chief Financial Officer
Received 104,000 shares as a grant or award · Granted 56,000 Employee Stock Option (right to buy) |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 11 Aug 2026 | EFFECT |
| 11 Aug 2026 | EFFECT |
| 06 Aug 2026 | EFFECT |
| 05 Aug 2026 | S-8 |
| 05 Aug 2026 | S-3 |
| 05 Aug 2026 | POS AM |
| 05 Aug 2026 | 424B3 |
| 05 Aug 2026 | S-3 |
| 05 Aug 2026 | 10-Q |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition
SAN DIEGO, Aug. 5, 2026 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the quarter ended June 30, 2026, and provided a company update. |
| 28 Jul 2026 |
Form 3: Grant-Huerta Yanina, Chief Financial Officer
No securities owned |
| 28 Jul 2026 |
Form 4: Yarema Kristin, Director
Received 38,376 shares by exercise or conversion · Acquired 115,129 shares (Other Transaction) · Disposed of 115,129 Restricted Stock Units (Other Transaction) |
| 23 Jul 2026 | 424B3 |
| 23 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Other Events
The ImageneBio, Inc. Severance and Change in Control Plan (the “Plan”) is hereby established by the Compensation Committee of the Board of Directors of ImageneBio, Inc. (the “Company”) effective as of April 27, 2026. The purpose of the P... |
Loading...